Bringing new hope to patients with the most difficult to treat cancers.
Shifting the paradigm.
TAE Life Sciences has exclusively licensed the patented particle accelerator technology developed by TAE for its pioneering work in fusion for a breakthrough biologically-guided radiation therapy based on Boron Neutron Capture Therapy (BNCT). TAE Life Sciences is developing comprehensive target drugs and a compact, cost-effective Alphabeam™ neutron source optimized to bring this promising treatment to patients and clinicians globally.
What is TAE Life Sciences?
TAE Life Sciences is a biotechnology company that was spun out by TAE Technologies in 2017 to develop and commercialize a breakthrough biologically targeted radiation treatment for the most difficult cancers. TAE Life Sciences’ Alphabeam™ neutron system is compact and practical for installation in a hospital setting.